330 related articles for article (PubMed ID: 34465026)
61. Genomic plasticity of the human fungal pathogen Candida albicans.
Selmecki A; Forche A; Berman J
Eukaryot Cell; 2010 Jul; 9(7):991-1008. PubMed ID: 20495058
[TBL] [Abstract][Full Text] [Related]
62. Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata.
Singh-Babak SD; Babak T; Diezmann S; Hill JA; Xie JL; Chen YL; Poutanen SM; Rennie RP; Heitman J; Cowen LE
PLoS Pathog; 2012; 8(5):e1002718. PubMed ID: 22615574
[TBL] [Abstract][Full Text] [Related]
63. Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans.
Vediyappan G; Rossignol T; d'Enfert C
Antimicrob Agents Chemother; 2010 May; 54(5):2096-111. PubMed ID: 20194705
[TBL] [Abstract][Full Text] [Related]
64. Chromosome 5 monosomy of Candida albicans controls susceptibility to various toxic agents, including major antifungals.
Yang F; Kravets A; Bethlendy G; Welle S; Rustchenko E
Antimicrob Agents Chemother; 2013 Oct; 57(10):5026-36. PubMed ID: 23896475
[TBL] [Abstract][Full Text] [Related]
65. Beauvericin Potentiates Azole Activity via Inhibition of Multidrug Efflux, Blocks Candida albicans Morphogenesis, and Is Effluxed via Yor1 and Circuitry Controlled by Zcf29.
Shekhar-Guturja T; Tebung WA; Mount H; Liu N; Köhler JR; Whiteway M; Cowen LE
Antimicrob Agents Chemother; 2016 Dec; 60(12):7468-7480. PubMed ID: 27736764
[TBL] [Abstract][Full Text] [Related]
66. An update on antifungal targets and mechanisms of resistance in Candida albicans.
Akins RA
Med Mycol; 2005 Jun; 43(4):285-318. PubMed ID: 16110776
[TBL] [Abstract][Full Text] [Related]
67. The Monoterpene Carvacrol Generates Endoplasmic Reticulum Stress in the Pathogenic Fungus Candida albicans.
Chaillot J; Tebbji F; Remmal A; Boone C; Brown GW; Bellaoui M; Sellam A
Antimicrob Agents Chemother; 2015 Aug; 59(8):4584-92. PubMed ID: 26014932
[TBL] [Abstract][Full Text] [Related]
68. Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis.
Laverdière M; Lalonde RG; Baril JG; Sheppard DC; Park S; Perlin DS
J Antimicrob Chemother; 2006 Apr; 57(4):705-8. PubMed ID: 16464893
[TBL] [Abstract][Full Text] [Related]
69. Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicans.
Ellepola AN; Khajah R; Jayatilake S; Samaranayake L; Sharma P; Khan Z
J Appl Oral Sci; 2015; 23(4):412-8. PubMed ID: 26398514
[TBL] [Abstract][Full Text] [Related]
70. In vitro activity of verapamil alone and in combination with fluconazole or tunicamycin against Candida albicans biofilms.
Yu Q; Ding X; Xu N; Cheng X; Qian K; Zhang B; Xing L; Li M
Int J Antimicrob Agents; 2013 Feb; 41(2):179-82. PubMed ID: 23265915
[TBL] [Abstract][Full Text] [Related]
71. Functional Genomic Screening Reveals Core Modulators of Echinocandin Stress Responses in Candida albicans.
Caplan T; Polvi EJ; Xie JL; Buckhalter S; Leach MD; Robbins N; Cowen LE
Cell Rep; 2018 May; 23(8):2292-2298. PubMed ID: 29791841
[TBL] [Abstract][Full Text] [Related]
72. The Rim Pathway Mediates Antifungal Tolerance in Candida albicans through Newly Identified Rim101 Transcriptional Targets, Including Hsp90 and Ipt1.
Garnaud C; García-Oliver E; Wang Y; Maubon D; Bailly S; Despinasse Q; Champleboux M; Govin J; Cornet M
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311085
[TBL] [Abstract][Full Text] [Related]
73. Generation of mutants in Candida albicans with reduced susceptibility to caspofungin: influence on other antifungal products.
Soler L; Rodriguez JC; Belda S; Cremades R; Ruiz-Garcia M; Lopez P; Royo G
J Chemother; 2010 Aug; 22(4):283-4. PubMed ID: 20685636
[No Abstract] [Full Text] [Related]
74. Evolution of Fluconazole-Resistant Candida albicans Strains by Drug-Induced Mating Competence and Parasexual Recombination.
Popp C; Ramírez-Zavala B; Schwanfelder S; Krüger I; Morschhäuser J
mBio; 2019 Feb; 10(1):. PubMed ID: 30723130
[TBL] [Abstract][Full Text] [Related]
75. Mutants of Candida albicans hypersensitive to calcofluor white display susceptibility to antifungal drugs.
He ZM; Chen J; Li HZ; Luo DQ; Yang W
Folia Microbiol (Praha); 2010 Mar; 55(2):159-66. PubMed ID: 20490759
[TBL] [Abstract][Full Text] [Related]
76. Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).
Kritikos A; Neofytos D; Khanna N; Schreiber PW; Boggian K; Bille J; Schrenzel J; Mühlethaler K; Zbinden R; Bruderer T; Goldenberger D; Pfyffer G; Conen A; Van Delden C; Zimmerli S; Sanglard D; Bachmann D; Marchetti O; Lamoth F;
Clin Microbiol Infect; 2018 Nov; 24(11):1214.e1-1214.e4. PubMed ID: 29909005
[TBL] [Abstract][Full Text] [Related]
77. Hsp90 stress potentiates rapid cellular adaptation through induction of aneuploidy.
Chen G; Bradford WD; Seidel CW; Li R
Nature; 2012 Jan; 482(7384):246-50. PubMed ID: 22286062
[TBL] [Abstract][Full Text] [Related]
78. Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing.
Desnos-Ollivier M; Bretagne S; Raoux D; Hoinard D; Dromer F; Dannaoui E;
Antimicrob Agents Chemother; 2008 Sep; 52(9):3092-8. PubMed ID: 18591282
[TBL] [Abstract][Full Text] [Related]
79. Evolution of drug resistance in Candida albicans.
Cowen LE; Anderson JB; Kohn LM
Annu Rev Microbiol; 2002; 56():139-65. PubMed ID: 12142485
[TBL] [Abstract][Full Text] [Related]
80. The Hsp90 co-chaperone Sgt1 governs Candida albicans morphogenesis and drug resistance.
Shapiro RS; Zaas AK; Betancourt-Quiroz M; Perfect JR; Cowen LE
PLoS One; 2012; 7(9):e44734. PubMed ID: 22970302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
